Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese - Factor VII polymorphism and coronary disease

By Shimokata K.   Kondo T.   Ohno M.   Takeshita K.   Inden Y.   Iino S.   Saito H.   Hirai M.  

Thrombosis Research, Vol. 105, Iss. 6, 2002-03 ,pp. : 493-498

Elsevier

Access to resources Recommend Favorite

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

Blood Cell Activation, Coagulation, and Inflammation in Men and Women With Coronary Artery Disease

By Lindmark E.   Wallentin L.   Siegbahn A.  

Thrombosis Research, Vol. 103, Iss. 3, 2001-08 ,pp. : 249-259

Elsevier

Access to resources Recommend Favorite

High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population

By Luca Giuseppe  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 458-463

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of tissue factor as a novel approach to anticoagulation in patients with coronary artery disease

By Ruff Christian T   Giugliano Robert   Morrow David A  

Future Cardiology, Vol. 2, Iss. 1, 2006-01 ,pp. : 85-91

Future Medicine

Access to resources Recommend Favorite